C07F 9/4403
The acid moiety containing a substituent or a structure which is considered
Official title: {the acid moiety containing a substituent or a structure which is considered as characteristic}
C07F9/4403 (The acid moiety containing a substituent or a structure which is considered) appears on 106 US grants and 80 published applications in this corpus.
Search patents in C07F- Granted patents
- 106
- Published applications
- 80
- Assignees
- 48
- Inventors
- 169
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 2 |
| 2003 | 1 | 3 |
| 2004 | 5 | 9 |
| 2005 | 4 | 5 |
| 2006 | 4 | 5 |
| 2007 | 2 | 4 |
| 2008 | 3 | 2 |
| 2009 | 3 | 3 |
| 2010 | 5 | 3 |
| 2011 | 2 | 1 |
| 2012 | 4 | 7 |
| 2013 | 4 | 6 |
| 2014 | 4 | 3 |
| 2015 | 5 | 3 |
| 2016 | 1 | 0 |
| 2017 | 2 | 3 |
| 2018 | 3 | 4 |
| 2019 | 2 | 6 |
| 2020 | 4 | 3 |
| 2021 | 3 | 3 |
| 2022 | 0 | 0 |
| 2023 | 2 | 4 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07F 9/4407Amides of acyclic saturated acids which can have further substituents on alkyl49
- C07F 9/4423Amides of poly phosphonic acids35
- C07F 9/4419Amides of aromatic acids22
- C07F 9/4426Amides of arylalkanephosphonic acids5
- C07F 9/443Amides of acids containing the structure -c-p-n or nc-1
- C07F 9/4411Amides of acyclic unsaturated acids0
- C07F 9/4415Amides of cycloaliphatic acids0
Recent patents
- Cannabidiol derivatives, preparation method thereof and use thereof10 Feb 2026US 12,545,694 B2Chengdu Baiyu Pharmaceutical Co., Ltd
- ENPP1 inhibitors and their use for the treatment of cancer25 Jul 2023US 11,707,471 B2The Board of Trustees of the Leland Stanford Junior University
- ENPP1 inhibitors and their use for the treatment of cancer18 Jul 2023US 11,701,371 B2The Board of Trustees of the Leland Stanford Junior University
- Chiral phosphoramidimidates and derivatives thereof10 Aug 2021US 11,084,834 B2Studiengesellschaft Kohle mbH
- Prodrugs of nucleoside phosphonates22 Jun 2021US 11,040,047 B2Katholieke Universiteit Leuven
- ENPP1 Inhibitors and Their Use for the Treatment of Cancer7 Sep 2023US 2023/0277570 A1The Board of Trustees of the Leland Stanford Junior University
- Hydroxyl compounds and compositions for cholesterol management and related uses6 Jul 2023US 2023/0210800 A1Esperion Therapeutics, Inc.
- ENPP1 Inhibitors and Their Use for the Treatment of Cancer6 Apr 2023US 2023/0103498 A1The Board of Trustees of the Leland Stanford Junior University
- Cannabidiol derivatives, preparation method thereof and use thereof5 Jan 2023US 2023/0002425 A1Chengdu Baiyu Pharmaceutical Co., Ltd
- Hydroxyl compounds and compositions for cholesterol management and related uses23 Dec 2021US 2021/0395175 A1Esperion Therapeutics, Inc.
Most cited
By later US patents
- Sulfide and disulfide compounds and compositions for cholesterol management and related uses68US 6,703,422 B2Esperion Therapeutics, Inc. · 2004
- Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses65US 6,673,780 B2Esperion Therapeutics, Inc. · 2004
- Ketone compounds and compositions for cholesterol management and related uses56US 6,699,910 B2Esperion Therapeutics, Inc. · 2004
- Ether compounds and compositions for cholesterol management and related uses35US 6,713,507 B2Esperion Therapeutics, Inc. · 2004
- Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses34US 7,405,226 B2Pfizer Inc. · 2008